AAPP has recently released a summary of recommended policy actions to support updates to psychotropic prescribing regulations and access to evidence-based monitoring for youth prescribed antipsychotics, including routine metabolic and other side effect monitoring. Check out this policy brief and ask and use it as a tool in your own advocacy.